https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-15 / Cancer 2005 Feb;103(4):763-71
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-15 / Cancer 2005 Feb;103(4):763-712005-02-15 00:00:002019-02-15 08:35:13A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Int. J. Oncol. 2005 Feb;26(2):431-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Int. J. Oncol. 2005 Feb;26(2):431-92005-02-01 00:00:002020-06-23 09:39:16Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Scand. J. Immunol. 2005 Feb;61(2):147-562005-02-01 00:00:002019-02-15 08:50:24Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / Int J Hyperthermia 2005 Feb;21(1):45-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / Int J Hyperthermia 2005 Feb;21(1):45-552005-02-01 00:00:002019-02-15 09:17:49A thermometry system for quality assurance and documentation of whole body hyperthermia procedures
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2005-02-01 / HBPD INT 2005 Feb;4(1):121-5
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2005-02-01 / HBPD INT 2005 Feb;4(1):121-52005-02-01 00:00:002019-02-15 08:36:23Effects of dendritic cells transfected with full length wild-type p53 and modified by bile duct cancer lysates on immune response
